CRMP-2 peptide mediated decrease of high and low voltage-activated calcium channels, attenuation of nociceptor excitability, and anti-nociception in a model of AIDS therapy-induced painful peripheral neuropathy
about
Neuronal networks in mental diseases and neuropathic pain: Beyond brain derived neurotrophic factor and collapsin response mediator proteinsCollapsin response mediator protein 2: high-resolution crystal structure sheds light on small-molecule binding, post-translational modifications, and conformational flexibility.Differential neuroprotective potential of CRMP2 peptide aptamers conjugated to cationic, hydrophobic, and amphipathic cell penetrating peptidesInhibition of transmitter release and attenuation of anti-retroviral-associated and tibial nerve injury-related painful peripheral neuropathy by novel synthetic Ca2+ channel peptides.Suppression of pain-related behavior in two distinct rodent models of peripheral neuropathy by a homopolyarginine-conjugated CRMP2 peptide.SUMOylation alters CRMP2 regulation of calcium influx in sensory neurons.Challenging the catechism of therapeutics for chronic neuropathic pain: Targeting CaV2.2 interactions with CRMP2 peptides.Sustained relief of neuropathic pain by AAV-targeted expression of CBD3 peptide in rat dorsal root ganglion.Efficacy of (S)-Lacosamide in preclinical models of cephalic pain.Collapsin response mediator protein 2 (CRMP2) interacts with N-methyl-D-aspartate (NMDA) receptor and Na+/Ca2+ exchanger and regulates their functional activity.Modulation of nociceptive ion channels and receptors via protein-protein interactions: implications for pain relief.CRMPs: critical molecules for neurite morphogenesis and neuropsychiatric diseases.Sustained relief of ongoing experimental neuropathic pain by a CRMP2 peptide aptamer with low abuse potential.Homology-guided mutational analysis reveals the functional requirements for antinociceptive specificity of collapsin response mediator protein 2-derived peptides.Combined chronic blockade of hyper-active L-type calcium channels and NMDA receptors ameliorates HIV-1 associated hyper-excitability of mPFC pyramidal neurons.A membrane-delimited N-myristoylated CRMP2 peptide aptamer inhibits CaV2.2 trafficking and reverses inflammatory and postoperative pain behaviors.Sodium hydrosulfide relieves neuropathic pain in chronic constriction injured rats.CRMP2-Neurofibromin Interface Drives NF1-related Pain.CRMP2 and voltage-gated ion channels: potential roles in neuropathic pain
P2860
Q26750915-5AAB0179-4783-4EF4-B6F8-13230FCBC22AQ30396999-F39ABF09-F4A7-4974-9539-F6A80EBE8D2BQ35012677-F7EE2EBA-4AD7-4B83-8647-6A59314EE852Q36318896-C2F1487D-08F1-48E1-A8B4-EF2520CB1D9EQ36644488-09F90255-2592-4523-A5CC-B97C95D67F35Q37009051-5FE3269A-020E-4458-A571-BB2529B2781AQ37360619-FDAE21BB-028A-4F3E-8EDB-DDAC3C5EC787Q37434396-00F95911-0BEF-4D93-B3E6-F35FAAD618FBQ37451570-EA3D88C9-B89A-4B45-9976-9A719CAF1F58Q37635778-494098FD-E710-4D1A-BE3F-2FBC5FE48BB5Q38514549-8B760594-6421-4131-984F-1F528A795C7CQ38528533-7E49BABC-8FDF-4B14-A6FB-E23EF022EA63Q39168504-4B936DE5-054D-477D-BC40-3F00FCFDA61DQ40349390-46FC44B4-A737-4360-9FC8-13D239EB1350Q40689880-DD2FB6C3-5A82-48E8-8DA7-3114BB64CB0EQ41202785-FBB5C878-C41E-4D90-9F5E-FB7EC617565BQ42541859-2E70356B-ED49-444F-9EE1-33D5D2B22E64Q52431558-7E578D4D-AB8D-4502-BC00-22482928EBA4Q58582878-FC3736A4-CAE7-4DA0-8F25-78FD64EB215D
P2860
CRMP-2 peptide mediated decrease of high and low voltage-activated calcium channels, attenuation of nociceptor excitability, and anti-nociception in a model of AIDS therapy-induced painful peripheral neuropathy
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
CRMP-2 peptide mediated decrea ...... painful peripheral neuropathy
@ast
CRMP-2 peptide mediated decrea ...... painful peripheral neuropathy
@en
type
label
CRMP-2 peptide mediated decrea ...... painful peripheral neuropathy
@ast
CRMP-2 peptide mediated decrea ...... painful peripheral neuropathy
@en
prefLabel
CRMP-2 peptide mediated decrea ...... painful peripheral neuropathy
@ast
CRMP-2 peptide mediated decrea ...... painful peripheral neuropathy
@en
P2093
P2860
P356
P1433
P1476
CRMP-2 peptide mediated decrea ...... painful peripheral neuropathy
@en
P2093
Andrew D Piekarz
Fletcher A White
Matthew S Ripsch
May Khanna
Michael R Due
Michael R Vasko
Rajesh Khanna
Ruizhong Wang
Samy O Meroueh
P2860
P2888
P356
10.1186/1744-8069-8-54
P577
2012-07-24T00:00:00Z
P5875
P6179
1046595132